R&D Systems™ Mouse CLEC-2/CLEC1B, Carrier-Free Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 9117CL050
DescriptionThe Recombinant Mouse CLEC-2/CLEC1B Protein is derived from NS0. The Recombinant Mouse CLEC-2/CLEC1B Protein has been validated for the following applications: Bioactivity.
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining|
|Mouse myeloma cell line,NS0-derived mouse CLEC-2/CLEC1B protein Met53-Leu229,with an N-terminal 6-His tag|
|<0.10 EU per 1μg of the protein by the LAL method.|
|Measured by its binding ability in a functional ELISA. When Recombinant Mouse Podoplanin Fc Chimera is coated at 0.5μg/mL (100μL/well), Recombinant Mouse CLEC-2/CLEC1B binds with a typical ED50 of 0.1-0.5μg/mL.|
|Mouse myeloma cell line, NS0-derived Met53-Leu229, with an N-terminal 6-His tag|
|Observed M.W.: 24-39kDa, reducing conditions, Theoretical M.W.: 21kDa|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|1810061I13Rik, CLEC1B, CLEC2, CLEC-2, CLEC2B, CLEC2PRO1384, C-type lectin domain family 1 member B, C-type lectin domain family 1, member B, C-type lectin-like receptor 2, C-type lectin-like receptor-2, QDED721|